Although widespread aneuploidy is typically regarded as a hallmark of advanced cancer stages (Ben-David and Amon 2019), specific copy number changes, like CDKN2A deletions, have been documented to sometimes occur early in lung adenocarcinoma development (Nahar et al. 2018, Watkins et al. 2020). This evidence concerns the gene CDKN2A and cancer.